Skip to content

Stateside DailyAll America

Search Get alerts

Home›Health›1 sources

Health · 1 sources covering this

STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs

An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/69d26a91ed83dd9ae317bc48b4bb9a9dff0c89fe"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs"></iframe>

More from Health

STAT·1h ago

Outbreak of diarrhea-causing parasite grows to more than 1,000 cases

STAT·1h ago

STAT+: FDA finalists under review

Daily briefing

Stateside Daily in your inbox

The 5 stories from all america you actually need to read. Once a day, no fluff. Unsubscribe in one click.

Stateside Daily

About
Methodology
Sources
Careers
Contact
Editorial standards

Sections

Politics
Business
Markets

STAT

·

1h ago

STAT+: Prime wins Beam arbitration, clearing path to clinic

STAT·2h ago

STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more

Reader

Today's briefing
Archive
Topics
Editorial guides
Notifications
Embed widgets
Bookmarks
Search

Trust & legal

Coverage stats
Corrections
Privacy
Terms
Security

Across the network

Hindustan Sphere
All India in one feed

© 2026 Stateside Daily. All headlines are sourced from third-party publishers; we never republish article bodies.

All America

STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs · Stateside Daily